Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPocc: IV Paclitaxel + IV vs IP Carboplatin in Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT01506856Phase 3Completed
- Sponsor
- Gynecologic Oncology Trial and Investigation Consortium
- Start
- May 2010
- Primary completion
- Feb 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 6
01
Overview
A Phase 3 trial of carboplatin in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by Gynecologic Oncology Trial and Investigation Consortium. Started May 2010; status: completed.
02
Drugs
carboplatin
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT01506856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506856.